Ryan Clarke

Ryan Clarke is the founding CEO of Syntax Bio and currently serving as the CTO. Ryan was trained as a developmental biologist with a specialty in CRISPR systems before launching Syntax, which has built an epigenetic programming system termed Cellgorithms for controlling stem cell fates for cell therapy applications.  



Tuesday
May 06
AI 'Cheat Codes' Speed Therapeutic Cell Creation via Transcription Factors
4:30 PM

-

5:15 PM

One of the biggest challenges faced by the regenerative medicine field today is the ability to efficiently and scalably generate therapeutic cells. This session explores cutting-edge transcription factor-based approaches for rapid and efficient differentiation of stem cells into therapeutic cell types. We will examine how synthetic biology techniques are revolutionizing cell therapy by enabling faster production of clinically relevant cells. Speakers will discuss recent advances, challenges, and future directions in harnessing transcription factors for directed differentiation, with a focus on applications in regenerative medicine and drug discovery.

Wednesday
May 07
The Living Future: How SynBio, Genomics, and Regenerative Medicine are Transforming Human Health
4:30 PM

-

5:15 PM

Synthetic biology is blurring the lines between biology and technology, unlocking breakthroughs in regenerative medicine, biofabrication, and personalized healthcare. This panel brings together leading innovators who are shaping the future of human health. Join this session to explore the role of multidisciplinary technologies in healthcare. Understand how genomics, synthetic biology, and regenerative medicine are personalizing treatment and examine the ethical and practical challenges in deploying next-gen biotechnologies.

Other Speakers

Social Media

Other

Copyright SynBioBeta 2025

Social Media

Other

Copyright SynBioBeta 2025

Social Media

Other

Copyright SynBioBeta 2025